In this Viewpoint, Peter Bach and colleagues distinguish 5 pricing reform proposals implied by the concept of value-based drug pricing and discuss the potential of each to ensure value in response to unsustainable drug price increases.
No takes yet. Share an insight, caveat, or question.
Kaltenboeck et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: